Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

"The initial presentation typically includes dementia and neurological symptoms such as ataxia, myoclonus, and gait abnormalities as well as behavioral changes," Cetin and co-authors wrote. Sporadic ...

Abstract: Amyotrophic lateral sclerosis (ALS) is a multisystem neurodegenerative ... networks engaged prior to motor output is essential for understanding the motor pathophysiology in ALS. We recorded ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting the upper and lower motor neurons. A key clinical feature of ALS is the absence of accurate, early-stage ...

Background Focality of onset of amyotrophic lateral sclerosis (ALS) is not understood ... results are potentially consistent with the hypothesis that exercise influences pathogenesis in ALS since ...

Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease ... offering new insights into disease pathogenesis and potential therapeutic targets. This Research Topic ...

Announcing a new publication for Acta Materia Medica journal. Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS) significantly hinder the develo ...

A research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other neurodegenerative disorders such as ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other ...